baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Dynavax Technologies Corp/ US2681582019 /

06/06/2024 22:00:00	Chg. +0.1700	Volume	Bid11:14:33	Ask11:14:33	Market Capitalization	Dividend Y.	P/E Ratio
12.2700USD	+1.40%	1.45 mill. Turnover: 14.09 mill.	12.0000Bid Size: 100	13.1000Ask Size: 100	1.61 bill.USD	-	-

GlobeNewswire 15/05 Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 26/03 MannKind Announces CFO Transition

GlobeNewswire 26/03 Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate

GlobeNewswire 06/03 ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Va...

GlobeNewswire 08/01 Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical O...

GlobeNewswire 11/03/2022 Valneva Provides Regulatory Update on its COVID-19 Vaccine Candidate

GlobeNewswire 01/03/2022 Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA20...

GlobeNewswire 25/02/2022 Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate V...

GlobeNewswire 25/01/2022 Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine Candidate

GlobeNewswire 19/01/2022 Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant

GlobeNewswire 06/01/2022 Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vac...

GlobeNewswire 23/12/2021 Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site

GlobeNewswire 16/12/2021 Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Cand...

GlobeNewswire 08/12/2021 Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001

GlobeNewswire 03/12/2021 Valneva Comments on COV-Boost Clinical Trial Data

GlobeNewswire 02/12/2021 Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine ...

GlobeNewswire 29/11/2021 Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2...

GlobeNewswire 23/11/2021 Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA20...

GlobeNewswire 10/11/2021 Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million D...

GlobeNewswire 04/11/2021 Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results

GlobeNewswire 02/11/2021 Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel

GlobeNewswire 18/10/2021 Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2...

GlobeNewswire 23/09/2021 Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001

GlobeNewswire 14/09/2021 Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 V...

GlobeNewswire 13/09/2021 Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government

Dynavax Technologies Corp/ US2681582019 /

If you wish to receive reply to your feedback, please provide your email address.